Increased risk of myocardial infarction as first manifestation of ischaemic heart disease and nonselective nonsteroidal anti-inflammatory drugs

This publication has 33 references indexed in Scilit:

• Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention
  New England Journal of Medicine, 2005
• Role of Prostacyclin in the Cardiovascular Response to Thromboxane A ₂
  Science, 2002
• Do Lipids, Blood Pressure, Diabetes, and Smoking Confer Equal Risk of Myocardial Infarction in Women as in Men? the Reykjavik Study
  European Journal of Preventive Cardiology, 2002
• Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleeding
  Alimentary Pharmacology & Therapeutics, 2002
• Comparison of cardiovascular thrombotic events in patients with osteoarthritis treated with Rofecoxib versus nonselective nonsteroidal anti-inflammatory drugs (Ibuprofen, Diclofenac, and Nabumetone)
  The American Journal of Cardiology, 2002
• Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease: an observational cohort study
  The Lancet, 2002
• Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
  New England Journal of Medicine, 2001
• Cardiovascular Thrombotic Events in Controlled, Clinical Trials of Rofecoxib
  Circulation, 2001
• Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis
  New England Journal of Medicine, 2000
• Differential Effects of Aspirin and Non-Aspirin Nonsteroidal Antiinflammatory Drugs in the Primary Prevention of Myocardial Infarction in Postmenopausal Women
  Epidemiology, 2000